TRIAMCINOLONE ACETONIDE

CAS Number: 76-25-5

Molecular Formula: C24H31FO6

About TRIAMCINOLONE ACETONIDE

Triamcinolone acetonide (CAS 76-25-5) remains a cornerstone in the US dermatological and ophthalmic sectors, where its specialized use in high purity fine chemicals for corticosteroid-responsive dermatoses and diabetic macular edema is driving demand for domestic cGMP-compliant manufacturing. Kenalog, as a leading synt...

TRIAMCINOLONE ACETONIDE Specifications

CAS Number

76-25-5

Molecular Formula

C24H31FO6

Molecular Weight

434.50 g/mol

IUPAC Name

(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one

Canonical SMILES

CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C

InChI Key

YNDXUCZADRHECN-JNQJZLCISA-N

PubChem CID

6436.0

CAS Number

76-25-5

Molecular Formula

C24H31FO6

Molecular Weight

434.50 g/mol

IUPAC Name

(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one

Canonical SMILES

CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C

InChI Key

YNDXUCZADRHECN-JNQJZLCISA-N

PubChem CID

6436.0

Molecular Weight

434.50 g/mol

Physical appearance

White to off-white powder or crystal

Pharmaceutical Agent

A synthetic glucocorticoid corticosteroid used as an anti-inflammatory and antipruritic agent to treat various skin conditions, allergic rhinitis, mouth sores, and joint inflammation

Anti-inflammatory Agent

A potent medication that works by activating natural substances in the skin or binding to glucocorticoid receptors to reduce swelling, redness, and itching

Immunosuppressive Agent

A therapeutic compound utilized to calm overactive immune systems and treat autoimmune disorders such as psoriasis, eczema, rheumatoid arthritis, and ulcerative colitis

Diagnostic Research Standard

A fluorinated steroid used in academic and clinical research to study glucocorticoid receptor interactions and the development of topical or systemic corticosteroid delivery systems.